![Marc d'Abbadie](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Marc d'Abbadie
Directeur/Membre du Conseil chez Spark Nw Carry Partner LLP
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Susan Foden | M | 71 | 10 ans | |
Stephen Bloor | M | - |
Videregen Ltd.
![]() Videregen Ltd. BiotechnologyHealth Technology Videregen Ltd. operates a regenerative medicine company created to address the chronic shortage of organs for transplantation in the field of tissue decellularisation, regenerative technologies and translation from laboratory to market. Its platform technology uses decellularised organ scaffolds seeded with the patient’s own cells to create non-immunogenic, regenerative bespoke organ replacements. The company was founded by Stephen Bloor in 2011 and is headquartered in Liverpool, The United Kingdom. | 13 ans |
Alan Barge | M | - | 9 ans | |
Jonathan Charles Gee | M | 71 |
SPARK Impact Ltd.
![]() SPARK Impact Ltd. Investment ManagersFinance SPARK Impact Ltd (SPARK Impact) is a venture capital firm founded in 2010. The firm is headquartered in North East, United Kingdom. | - |
Martin Hunt | M | 66 |
Videregen Ltd.
![]() Videregen Ltd. BiotechnologyHealth Technology Videregen Ltd. operates a regenerative medicine company created to address the chronic shortage of organs for transplantation in the field of tissue decellularisation, regenerative technologies and translation from laboratory to market. Its platform technology uses decellularised organ scaffolds seeded with the patient’s own cells to create non-immunogenic, regenerative bespoke organ replacements. The company was founded by Stephen Bloor in 2011 and is headquartered in Liverpool, The United Kingdom. | - |
Douglas Quinn | M | 69 |
Videregen Ltd.
![]() Videregen Ltd. BiotechnologyHealth Technology Videregen Ltd. operates a regenerative medicine company created to address the chronic shortage of organs for transplantation in the field of tissue decellularisation, regenerative technologies and translation from laboratory to market. Its platform technology uses decellularised organ scaffolds seeded with the patient’s own cells to create non-immunogenic, regenerative bespoke organ replacements. The company was founded by Stephen Bloor in 2011 and is headquartered in Liverpool, The United Kingdom. | - |
Mark Borzomato | M | - |
SPARK Impact Ltd.
![]() SPARK Impact Ltd. Investment ManagersFinance SPARK Impact Ltd (SPARK Impact) is a venture capital firm founded in 2010. The firm is headquartered in North East, United Kingdom. | 8 ans |
Robert Hollamby | M | - |
Videregen Ltd.
![]() Videregen Ltd. BiotechnologyHealth Technology Videregen Ltd. operates a regenerative medicine company created to address the chronic shortage of organs for transplantation in the field of tissue decellularisation, regenerative technologies and translation from laboratory to market. Its platform technology uses decellularised organ scaffolds seeded with the patient’s own cells to create non-immunogenic, regenerative bespoke organ replacements. The company was founded by Stephen Bloor in 2011 and is headquartered in Liverpool, The United Kingdom. | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Richard Moulson | M | - | - | |
John Bradshaw | M | 60 | - | |
Susan Clement Davies | F | 62 | 5 ans | |
Mark A. Wyatt | M | 51 | - | |
Hamina J. Patel | F | - | - | |
David Chadwick | M | - | 3 ans |
Statistiques
Pays | Relations | % du total |
---|---|---|
Royaume-Uni | 14 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Marc d'Abbadie
- Réseau Personnel